These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 28934293)
1. Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele. Wu J; Liu X; Nayak SG; Pitarresi JR; Cuitiño MC; Yu L; Hildreth BE; Thies KA; Schilling DJ; Fernandez SA; Leone G; Ostrowski MC PLoS One; 2017; 12(9):e0184984. PubMed ID: 28934293 [TBL] [Abstract][Full Text] [Related]
2. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677 [TBL] [Abstract][Full Text] [Related]
3. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice. Liao J; Chung YT; Yang AL; Zhang M; Li H; Zhang W; Yan L; Yang GY Mol Carcinog; 2013 Sep; 52(9):739-50. PubMed ID: 22549877 [TBL] [Abstract][Full Text] [Related]
4. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS. Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346 [TBL] [Abstract][Full Text] [Related]
5. Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1/Cre mouse model of pancreatic cancer. Lanza-Jacoby S; Yan G; Radice G; LePhong C; Baliff J; Hess R Exp Biol Med (Maywood); 2013 Jul; 238(7):787-97. PubMed ID: 23828595 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice. Bai H; Li H; Zhang W; Matkowskyj KA; Liao J; Srivastava SK; Yang GY Carcinogenesis; 2011 Nov; 32(11):1689-96. PubMed ID: 21859833 [TBL] [Abstract][Full Text] [Related]
8. A mouse model for high-efficient Flp-recombinase-mediated genetic manipulation in the pancreas. Zhu X; Chen J; Wang B; Wang L; Wang J; Feng D; Yang Y; Wang O; Haddock AN; Wang Y; Ji B; Bi Y Pancreatology; 2023 Sep; 23(6):736-741. PubMed ID: 37429756 [TBL] [Abstract][Full Text] [Related]
9. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis. Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595 [TBL] [Abstract][Full Text] [Related]
10. Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice. Lee CL; Moding EJ; Huang X; Li Y; Woodlief LZ; Rodrigues RC; Ma Y; Kirsch DG Dis Model Mech; 2012 May; 5(3):397-402. PubMed ID: 22228755 [TBL] [Abstract][Full Text] [Related]
11. LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest. Morton JP; Jamieson NB; Karim SA; Athineos D; Ridgway RA; Nixon C; McKay CJ; Carter R; Brunton VG; Frame MC; Ashworth A; Oien KA; Evans TR; Sansom OJ Gastroenterology; 2010 Aug; 139(2):586-97, 597.e1-6. PubMed ID: 20452353 [TBL] [Abstract][Full Text] [Related]
12. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer. Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379 [TBL] [Abstract][Full Text] [Related]
13. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer. Zhang S; Chung WC; Xu K Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302 [TBL] [Abstract][Full Text] [Related]
14. Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras. Asahina K; Balog S; Hwang E; Moon E; Wan E; Skrypek K; Chen Y; Fernandez J; Romo J; Yang Q; Lai K; French SW; Tsukamoto H Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G265-G276. PubMed ID: 31760766 [No Abstract] [Full Text] [Related]
15. Overall survival of pancreatic ductal adenocarcinoma is doubled by Lee JS; Lee H; Woo SM; Jang H; Jeon Y; Kim HY; Song J; Lee WJ; Hong EK; Park SJ; Han SS; Kim SY Theranostics; 2021; 11(7):3472-3488. PubMed ID: 33537098 [No Abstract] [Full Text] [Related]
16. Zeb1 in Stromal Myofibroblasts Promotes Sangrador I; Molero X; Campbell F; Franch-Expósito S; Rovira-Rigau M; Samper E; Domínguez-Fraile M; Fillat C; Castells A; Vaquero EC Cancer Res; 2018 May; 78(10):2624-2637. PubMed ID: 29490942 [TBL] [Abstract][Full Text] [Related]
17. Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting. Cheung PF; Neff F; Neander C; Bazarna A; Savvatakis K; Liffers ST; Althoff K; Lee CL; Moding EJ; Kirsch DG; Saur D; Bazhin AV; Trajkovic-Arsic M; Heikenwalder MF; Siveke JT Cancer Res; 2018 Sep; 78(17):4997-5010. PubMed ID: 29844119 [TBL] [Abstract][Full Text] [Related]
18. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. DiNorcia J; Lee MK; Moroziewicz DN; Winner M; Suman P; Bao F; Remotti HE; Zou YS; Yan SF; Qiu W; Su GH; Schmidt AM; Allendorf JD J Gastrointest Surg; 2012 Jan; 16(1):104-12; discussion 112. PubMed ID: 22052106 [TBL] [Abstract][Full Text] [Related]
19. The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis. Zhang M; Kirsch DG Dis Model Mech; 2015 Sep; 8(9):1155-66. PubMed ID: 26183214 [TBL] [Abstract][Full Text] [Related]
20. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes. Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]